Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 394.70
-1.15 (-0.29%)
Feb 26, 2026, 3:29 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 640.63 billion as of February 26, 2026. Its market cap has increased by 37.16% in one year.
Market Cap
640.63B
Enterprise Value
807.47B
Revenue
168.27B
Ranking
n/a
PE Ratio
83.15
Stock Price
394.70
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 640.63B, an increase of 1,310.68%. That is a compound annual growth rate of 12.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 640.63B | 21.88% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 391.08B |
| OneSource Specialty Pharma | 151.76B |
| Concord Biotech | 115.00B |
| Blue Jet Healthcare | 67.89B |
| Supriya Lifescience | 53.87B |
| Zota Health Care | 42.91B |
| Dishman Carbogen Amcis | 28.42B |
| Panacea Biotec | 20.83B |